The Effectiveness and Safety of Landiolol Hydrochloride, an Ultra-Short-Acting β1-Blocker, in Postoperative Patients with Supraventricular Tachyarrhythmias: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

American Journal of Cardiovascular Drugs

Volumn 13, Issue 5, 2013, Pages 353-364

  Taenaka, Nobuyuki ^a   Kikawa, Shinichi ^b  

^a TAKARAZUKA CITY HOSPITAL   (Japan)

^b ONO PHARMACEUTICAL CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LANDIOLOL; PLACEBO;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HEART MUSCLE ISCHEMIA; HEART VENTRICLE EXTRASYSTOLE; HIGH RISK PATIENT; HUMAN; HYPOTENSION; LOADING DRUG DOSE; MALE; MULTICENTER STUDY; PERSISTENT POSTOPERATIVE SUPRAVENTRICULAR TACHYARRHYTHMIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUPRAVENTRICULAR TACHYCARDIA; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; AGED; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HEART RATE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MORPHOLINES; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; TACHYCARDIA, SUPRAVENTRICULAR; TREATMENT OUTCOME; UREA;

EID: 84885161700     PISSN: 11753277     EISSN: 1179187X     Source Type: Journal    
DOI: 10.1007/s40256-013-0035-2     Document Type: Article

References (20)

1. Matloff JM, Wolfson S, Gorlin R, Harken DE. Control of postcardiac surgical tachycardias with propranolol. Circulation. 1968;37(4 Suppl):II-133-8.
2. Balser JR, Martinez EA, Winters BD, Perdue PW, Clarke AW, Huang W, et al. β-Adrenergic blockade accelerates conversion of postoperative supraventricular tachyarrhythmias. Anesthesiology. 1998;89:1052-9.
3. Gray RJ, Bateman TM, Czer LSC, Conklin CM, Matloff JM. Esmolol: a new ultrashort-acting beta-adrenergic blocking agent for rapid control of heart rate in postoperative supraventricular tachyarrhythmias. J Am Coll Cardiol. 1985;5:1451-6.
4. Mooss AN, Wurdeman RL, Mohiuddin SM, Reyes AP, Sugimoto JT, Scott W, et al. Esmolol versus diltiazem in the treatment of postoperative atrial fibrillation/atrial flutter after open heart surgery. Am Heart J. 2000;140:176-80.
5. Daoud EG. Management of atrial fibrillation in the post-cardiac surgery setting. Cardiol Clin. 2004;22:159-66.
6. 1-blocking agent in healthy volunteers. Rinsho Iyaku. 2000;16(10):1531-56 (in Japanese).
7. Yoshiya I, Ogawa R, Okumura F, Shimada Y, Hanaoka K. Clinical evaluation of landiolol hydrochloride (ONO-1101) on perioperative supraventricular tachyarrhythmia - a phase III, double-blind study in comparison with placebo. Rinsho Iyaku. 1997;13(19):4949-78 (in Japanese).
8. Halter JB, Pflug AE, Porte D. Mechanism of plasma catecholamine increases during surgical stress in man. J Clin Endocrinol Metab. 1977;45:936-44.
9. Kalman JM, Munawar M, Howes LG, Louis WJ, Buxton BF, Gutteridge G, et al. Atrial fibrillation after coronary artery bypass grafting is associated with sympathetic activation. Ann Thorac Surg. 1995;60:1709-15.
10. Breslow MJ, Jordan DA, Christopherson R, Rosenfeld B, Miller CF, Hanley DF, et al. Epidural morphine decreases postoperative hypertension by attenuating sympathetic nervous system hyperactivity. JAMA. 1989;261:3577-81.
11. Reves JG, Karp RB, Buttner EE, Tosone S, Smith LR, Samuelson PN, et al. Neuronal and adrenomedullary catecholamine release in response to cardiopulmonary bypass in man. Circulation. 1982;66(1):49-55.
12. Kirshenbaum JM, Kloner RA, Antman EM, Braunwald E. Use of an ultra short-acting β-blocker in patients with acute myocardial ischemia. Circulation. 1985;72(4):873-80.
13. Jacobs JR, Maier GW, Rankin JS, Reves JG. Esmolol and left ventricular function in the awake dog. Anesthesiology. 1988;68:373-8.
14. Murthy VS, Hwang TF, Zagar ME, Vollmer RR, Schmidt DH. Cardiovascular pharmacology of ASL-8025, an ultra-short acting β blocker. Eur J Pharmacol. 1983;94:43-51.
15. Reilly CS, Wood M, Koshakji RP, Wood AJJ. Ultra-short-acting beta-blockade: a comparison with conventional beta-blockade. Clin Pharmacol Ther. 1985;38:579-85.
16. Iguchi S, Iwamura H, Nishizaki M, Hayashi A, Senokuchi K, Kobayashi K, et al. Development of a highly cardioselective ultra short-acting β-blocker, ONO-1101. Chem Pharm Bull (Tokyo). 1992;40:1462-9.
17. Schwartz M, Michelson EL, Sawin HS, Macvaugh H III. Esmolol: safety and efficacy in postoperative cardiothoracic patients with supraventricular tachyarrhythmias. Chest. 1988;93(4):705-11.
18. Kaplan JA, Dunbar RW, Jones EL. Nitroglycerin infusion during coronary artery surgery. Anesthesiology. 1976;45:14-21.
19. Anderson S, Blanski L, Byrd RC, Das G, Engler R, Laddu A, et al. Comparison of the efficacy and safety of esmolol, a short-acting beta blocker, with placebo in the treatment of supraventricular tachyarrhythmias. The Esmolol vs Placebo Multicenter Study Group. Am Heart J. 1986;111:42-8.
20. Sasao J, Tarver SD, Kindscher JD, Taneyama C, Benson KT, Goto H. In rabbits, landiolol, a new ultra-short-acting β-blocker, exerts a more potent negative chronotropic effect and less effect on blood pressure than esmolol. Can J Anesth. 2001;48:985-9.